Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

a Phase 2 study of DISC-0974 in anemia of myelofibrosis (MF)

Next Previous
Trial Profile

a Phase 2 study of DISC-0974 in anemia of myelofibrosis (MF)

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 May 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DISC 0974 (Primary)
  • Indications Anaemia; Myelofibrosis
  • Focus Therapeutic Use
  • Acronyms RALLY-MF

Most Recent Events

  • 29 Apr 2025 According to Disc Medicine media release, company to discuss trial design of this study at a virtual KOL investor event to be hosted by company on Friday, May 9 at 1:00 PM ET / 10:00 AM PT to provide an overview of anemia of myelofibrosis (MF) and discuss the evolving treatment landscape for this disease.
  • 10 Jan 2025 According to the Disc Medicine Media Release, company announced Progress ongoing phase 2 MF anemia trial with initial data expected H2 2025
  • 09 Dec 2024 Status changed from planning to recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top